These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30055465)

  • 1. Synthesis and cytotoxic studies of novel 5-phenylisatin derivatives and their anti-migration and anti-angiogenic evaluation.
    Zhang Q; Teng Y; Yuan Y; Ruan T; Wang Q; Gao X; Zhou Y; Han K; Yu P; Lu K
    Eur J Med Chem; 2018 Aug; 156():800-814. PubMed ID: 30055465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Antiproliferatory Activities Evaluation of Multi-Substituted Isatin Derivatives.
    Ding Y; Zhao L; Fu Y; Hao L; Fu Y; Yuan Y; Yu P; Teng Y
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents.
    Han K; Zhou Y; Liu F; Guo Q; Wang P; Yang Y; Song B; Liu W; Yao Q; Teng Y; Yu P
    Bioorg Med Chem Lett; 2014 Jan; 24(2):591-4. PubMed ID: 24360564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
    Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives.
    Teng YO; Zhao HY; Wang J; Liu H; Gao ML; Zhou Y; Han KL; Fan ZC; Zhang YM; Sun H; Yu P
    Eur J Med Chem; 2016 Apr; 112():145-156. PubMed ID: 26890120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
    Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells.
    Yu B; Wang SQ; Qi PP; Yang DX; Tang K; Liu HM
    Eur J Med Chem; 2016 Nov; 124():350-360. PubMed ID: 27597411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
    Guo L; Chen W; Cao R; Fan W; Ma Q; Zhang J; Dai B
    Eur J Med Chem; 2018 Mar; 147():253-265. PubMed ID: 29448140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
    Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA
    Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives as Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.
    Zhang J; Liu T; Chen M; Liu F; Liu X; Zhang J; Lin J; Jin Y
    ChemMedChem; 2018 Jun; 13(12):1181-1192. PubMed ID: 29637713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
    Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
    J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole- Based Anticancer Agents as Potent Angiogenesis Inhibitors.
    Altuğ-Tasa B; Kaya-Çavuşoğlu B; Koparal AT; Turan G; Koparal AS; Kaplancıklı ZA
    Anticancer Agents Med Chem; 2021; 21(15):2041-2049. PubMed ID: 33390125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Tetrahydroisoquinoline Derivatives as Anti-Angiogenesis and Anti-Cancer Agents.
    Gangapuram M; Eyunni S; Zhang W; Redda KK
    Anticancer Agents Med Chem; 2021; 21(18):2505-2511. PubMed ID: 33438560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Characterization, and Anti-Cancer Activity of Some New N'-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives.
    El-Faham A; Farooq M; Khattab SN; Abutaha N; Wadaan MA; Ghabbour HA; Fun HK
    Molecules; 2015 Aug; 20(8):14638-55. PubMed ID: 26287132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, Anti-Proliferative, Anti-microbial, Anti-Angiogenic Activity and
    Ünver H; Berber B; Demirel R; Koparal AT
    Anticancer Agents Med Chem; 2019; 19(13):1658-1669. PubMed ID: 30887930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
    Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
    Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and anti-proliferative evaluation of [1,1'-biphenyl]-4-ols as inhibitor of HUVEC migration and tube formation.
    Ran Y; Ma L; Wang X; Chen J; Wang G; Peng A; Chen L
    Molecules; 2012 Jul; 17(7):8091-104. PubMed ID: 22766801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.